Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with ...
In a real-world analysis of patients with advanced RCC, the combination of first-line Bavencio and Inlyta was effective and ...
Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a ...
Patients with advanced urothelial carcinoma had prolonged survival with Bavencio and BSC treatment, regardless of diabetes ...
My pet provided emotional support and helped me tolerate chemotherapy better, reducing my stress and improving my well-being throughout my cancer journey.
Dr. Debu Tripathy breaks down the FDA approval of Enhertu in unresectable or metastatic HR-positive, HER2-low or -ultralow ...
SBRT improved local progression-free survival over RFA in small recurrent HCC, particularly in tumors 2 cm or less.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based ...
I often reflect on my emotional changes following a testicular cancer diagnosis and how I learned to manage them and grow.
Among patients with low-grade, intermediate-risk NMIBC, UGN-102 generated robust, durable responses in an analysis of the ...
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma ...
The FDA has granted orphan drug designation to the oral agent OPN-6602 for the treatment of patients with relapsed or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback